Navigation Links
New angel capital centered on GenTel agreement with big pharma

Madison, Wis. - GenTel BioSciences, a privately-held biotechnology company, has completed what it calls a critical round of financing activity by raising an additional $500,000 to pursue a new partnership with a large pharmaceutical company.

Alex Vodenlich, president and CEO of GenTel, said the identity of the pharma company would not be anno......

Full article >>> gov/Act255">Act 255, the state's investment tax credit program, and Wisconsin Investment Partners, a Madison-based angel investment network that emphasizes life-science investments.

"They [GenTel] have had good marketplace acceptance and nice sales growth, albeit for a young company," said Dick Leazer, a princi......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/20/07


Related biology technology :

1. Investor warns of angel-venture funding gap
2. Breaking down Wisconsins angel capital numbers
3. Research explains why women lack equal access to angel capital
4. Capital-raising term sheets for angels and venture capitalists
5. National angel investment grew 11 percent in `06
6. BioSystem Development secures angel funding
7. New Silicon Pastures director envisions more home cooking for Wisconsin angels
8. Milwaukee angel network invests in St. Louis company
9. Small Tree receives additional angel funding
10. Burke would like to double Act 255 angel tax credits
11. Midwest plays small role in VC investment, angel groups to the rescue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):